| Released | Contributor | Author | Title | Pages | Price |
|---|
| May 21, 2013 | New Constructs, LLC | N/A | VNDA: Due Diligence Review: Forensic Earnings and Valuation | 13 | $25 | | May 19, 2013 | Pechala's Reports | Lubomir Pechala | VANDA PHARMACEUTICALS INC (VNDA) - REPORT FOR ACTIVE TRADERS | 1 | $25 | | May 19, 2013 | Market Edge | N/A | Market Edge Equity Research Report | 4 | $10 | | May 19, 2013 | Market Edge | N/A | Market Edge Equity Research Report | 4 | $10 | | May 17, 2013 | Pechala's Reports | Frantisek Pechala | VANDA PHARMACEUTICALS INC (VNDA) 12-months forecast | 1 | $15 | | May 16, 2013 | Ford Investor Services, Inc. | N/A | Industry Value Graph: FOLD , CNDO , HALO , OPTR , OREX , GEVA , VNDA -- DRUGS | 3 | $34.50 | | May 16, 2013 | Ford Investor Services, Inc. | N/A | Value Graph: VANDA PHARMACEUT -- VNDA | 1 | $11.50 | | May 15, 2013 | ValuEngine, Inc. | N/A | ValuEngine Detailed Valuation Report for VNDA | 11 | $126.50 | | May 14, 2013 | Zacks Investment Research Inc. | N/A | VANDA PHARMACT (VNDA) Zacks Company Snapshot | 1 | $11.50 | | May 13, 2013 | Zacks Investment Research Inc. | N/A | VANDA PHARMACT (VNDA) Zacks Company Snapshot | 1 | $11.50 |
|
View All Reports for VNDA ... |
|
|
0.16(2.31%) 2:41PM EDT - Nasdaq Real Time Price